Can We Safely Target the WNT Pathway?

Nature Reviews Drug Discovery - United Kingdom
doi 10.1038/nrd4233
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

What Can We Plant Now, Safely /

1933English

Rehashing Endocannabinoid Antagonists: Can We Selectively Target the Periphery to Safely Treat Obesity and Type 2 Diabetes?

Journal of Clinical Investigation
Medicine
2010English

Early Discharge of Term Neonates: We Can Do It Safely

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2015English

How Can We Operate Safely in the Setting of Immunosuppression? Sims Et Al .

Colorectal Disease
Gastroenterology
2019English

MENA Is a Transcriptional Target of the WNT/Beta-Catenin Pathway

PLoS ONE
Multidisciplinary
2012English

Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?

Cells
2018English

CDK3, Target of miR-4469, Suppresses Breast Cancer Metastasis via Inhibiting WNT/Β-Catenin Pathway

Oncotarget
Oncology
2017English

The Optimal Kir Donor – We Can Recognize, but Can We Search?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Can Epileptic Patients on Carbamazepine Safely Fast Ramadan?

Journal of the Islamic Medical Association of North America
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy